LOGUERCIO, Carmelina
 Distribuzione geografica
Continente #
EU - Europa 14.275
NA - Nord America 6.440
AS - Asia 5.034
SA - Sud America 1.059
AF - Africa 74
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 26.895
Nazione #
RU - Federazione Russa 8.728
US - Stati Uniti d'America 6.341
SG - Singapore 1.997
IE - Irlanda 1.660
CN - Cina 1.015
UA - Ucraina 979
HK - Hong Kong 967
BR - Brasile 894
GB - Regno Unito 734
IT - Italia 669
DE - Germania 494
SE - Svezia 277
FI - Finlandia 262
VN - Vietnam 259
TR - Turchia 204
KR - Corea 194
FR - Francia 166
GR - Grecia 162
IN - India 113
JP - Giappone 95
AR - Argentina 65
IQ - Iraq 48
MX - Messico 38
EC - Ecuador 35
BD - Bangladesh 30
NL - Olanda 29
ID - Indonesia 28
CA - Canada 27
ZA - Sudafrica 24
AT - Austria 23
BE - Belgio 23
PY - Paraguay 16
ES - Italia 15
PK - Pakistan 15
CL - Cile 13
CO - Colombia 13
MA - Marocco 13
PL - Polonia 13
AU - Australia 11
DO - Repubblica Dominicana 10
PE - Perù 9
UZ - Uzbekistan 9
KE - Kenya 8
JM - Giamaica 7
MY - Malesia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
IR - Iran 6
MK - Macedonia 6
NP - Nepal 6
EG - Egitto 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
ET - Etiopia 4
HN - Honduras 4
LB - Libano 4
LT - Lituania 4
NG - Nigeria 4
SN - Senegal 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AZ - Azerbaigian 3
CH - Svizzera 3
JO - Giordania 3
KZ - Kazakistan 3
PH - Filippine 3
RO - Romania 3
SA - Arabia Saudita 3
TJ - Tagikistan 3
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GT - Guatemala 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
GY - Guiana 1
IL - Israele 1
IM - Isola di Man 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
Totale 26.889
Città #
Moscow 2.928
Dublin 1.657
Jacksonville 1.454
Hong Kong 962
Chandler 927
Santa Clara 708
Singapore 687
Princeton 275
Medford 228
Seoul 171
Beijing 169
Boardman 165
Ashburn 155
Roxbury 149
San Mateo 132
Ann Arbor 128
Wilmington 118
Hefei 101
Woodbridge 88
New York 87
Ho Chi Minh City 83
Dallas 82
Bengaluru 80
Naples 74
São Paulo 73
The Dalles 73
Caserta 62
Cambridge 61
Des Moines 54
Dong Ket 52
Bremen 47
Munich 46
Nanjing 43
Los Angeles 38
Hanoi 36
Düsseldorf 30
Jinan 29
Mountain View 21
Norwalk 20
Nuremberg 20
Belo Horizonte 19
Brussels 19
Brasília 18
Tianjin 18
Campinas 17
Duhok 17
Houston 17
Milan 17
Turku 17
Curitiba 16
Napoli 16
Rio de Janeiro 16
Boydton 15
Guangzhou 15
Kunming 15
Shanghai 15
Auburn Hills 14
Salvador 14
Redwood City 13
Rome 13
Tokyo 13
Venice 13
Porto Alegre 12
Vienna 12
Groningen 11
Hangzhou 11
Baghdad 10
Council Bluffs 10
Goiânia 10
Jinju 10
Quito 10
Shenyang 10
Zhengzhou 10
Changsha 9
Lanzhou 9
Manaus 9
San Francisco 9
Santiago 9
St Petersburg 9
São José 9
Tashkent 9
Atella 8
Catania 8
Dhaka 8
Falkenstein 8
Fortaleza 8
Helsinki 8
Nanchang 8
Osasco 8
Paris 8
Potenza 8
Santo Domingo 8
Asunción 7
Bologna 7
Guayaquil 7
Jakarta 7
Nairobi 7
Pelotas 7
Thái Bình 7
Betim 6
Totale 12.991
Nome #
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 196
Intrafamilial spread of Helicobacter pylori infection 181
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 177
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 176
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 163
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 161
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 161
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 160
Chronic inflammation and oxidative stress in human carcinogenesis 159
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 158
Crohn’s disease and skin 157
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 157
A case of hepatotoxicity caused by green tea 155
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 155
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 152
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 151
Gut-Brain Axis: a new revolution to understand the pathogenesis of autism and other severe neurological diseases 151
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 151
Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease 150
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 147
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 146
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 145
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 143
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 142
AISF position paper on liver disease and pregnancy 142
[Pentagastrin, a histamine H2 receptor inhibitor, and human salivary secretion] 137
About gut microbiota: Why? 137
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 137
A real-life study of new antiviral therapies in a high prevalence geographical area for hepatitis C virus infection 136
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 136
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 134
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 133
Studio nutrizionale del cirrotico. Confronto fra plicometria cutanea ed acqua corporea 133
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 132
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system] 132
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 132
[Diabetic neuropathy. I). Peripheral neuropathy] 131
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 131
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 130
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 129
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 129
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 129
age aggects glutathione content and glutathione- transferease activity in human gasstric mucosa 127
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 127
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 127
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 126
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 126
[Early neuropsychological changes in patients with nonalcoholic liver cirrhosis] 125
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 124
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 124
NUTRITIONAL STATUS IN LIVER CIRRHOSIS 123
Age affects glutathione content and glutathione-transferase activity in human gastric mucosa 123
Light alcohol drinking and the risk of cancer development: a controversial relationship 123
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 122
Trace elements and chronic liver diseases 121
L'alimentazione nel soggetto con epatite virale acuta e cronica 118
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 118
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 116
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 116
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 115
Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: a single-center retrospective study 115
[Gastrin stimulation of salivary secretion: preliminary observations] 115
[Nutritional problems in cirrhotic patients. Evaluation of dietetic aspects] 115
[Evaluation of the total hepatic function after treatment with fosinopril in hypertensive patients with liver cirrhosis] 114
Determination of plasma alpha-glutathione-S-transferases in chronic alcohol abusers: relationship with alcohol intake and liver involvement 114
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 114
Regional variations in total and nonprotein sulfhydryl compounds in the human gastric mucosa and effects of ethanol 113
Oxidative stress in viral and alcoholic hepatitis 112
The Impact of Diet on Liver Fibrosis and on Response to Interferon Therapy in Patients With HCV-Related Chronic Hepatitis. 112
L'uomo e il vino 112
Alcoholic hepatitis: Pathogenesis, diagnosis and treatment 112
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 112
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 111
Antioxidants in the treatment and prevention of gastric mucosal damage 111
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 110
Il “pianeta” fegato grasso nella pratica clinica. Dalla Diagnosi alla terapia 110
Gut microbiota and the liver 110
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 109
Secrezione salivare e tests strumentali di neuropatia diabetica autonoma 109
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 109
Una spia sulla tavola dei nostri ragazzi 108
Liver p53 expression in patients with HCV-related chronic hepatitis 107
Alterazione della sensibilità gustativa nel diabete mellito 107
Effetti metabolici della silibina: studi in vitro e in vivo. 107
Inhibitory effect of caerulein on salivary secretion in man 106
Percutaneous endoscopic gastrostomy for critically ill patients in a general intensive care unit. 106
Aspetti alimentari, stato nutrizionale e malattie dell’apparato digerente – Interazione nell’età evolutiva e nell’adulto 105
Effect of gastrin upon salivary flow rate in normal subject, duodenal ulcer and cirrhotic patients. 104
Nutrient intakes, nutritional patterns and the risk of liver cirrhosis: an esplorative case-control study 104
Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study 103
[Effect of cerulein on human salivary secretion] 103
Alcoholic liver disease and hepatitis C chronic infection 103
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 102
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. 101
Critical review on the use and abuse of alcohol. When the dose makes the difference 100
Management of chronic liver disease by general practitioners in southern Italy: unmet educational needs 99
Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies 99
Permeabilità intestinale e malattie epatiche. 99
Treatment of chronic hepatic encephalopathy with rifaximin. In: Encefalopatia epatica 99
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. 98
Totale 12.694
Categoria #
all - tutte 93.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.198 0 0 0 0 0 27 288 241 16 285 229 112
2021/20221.589 142 4 11 48 589 19 31 35 57 52 148 453
2022/20233.277 319 87 34 306 314 262 4 216 1.601 29 53 52
2023/20241.257 119 45 64 126 438 82 45 24 1 19 106 188
2024/20253.659 29 77 56 92 566 347 565 332 442 721 253 179
2025/202612.031 444 499 815 769 1.129 8.375 0 0 0 0 0 0
Totale 27.190